Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
immunAware ApS logo — Immune Monitoring T cells

immunAware ApS

Immune Monitoring T cells

Founded 2018 Denmark Denmark 8 employees Biotechnology, Life Sciences

General Information

Company Name immunAware ApS
Founded Year 2018
Location Denmark Denmark
Employees 8
Industries Biotechnology, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with immunAware ApS. To contact immunAware ApS, visit immunaware.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does immunAware ApS compare?

A PDF of immunAware ApS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting immunAware ApS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About immunAware ApS

immunAware ApS is a biotechnology startup that specializes in the biochemistry of MHC class I and II molecules. They offer a large collection of recombinant MHC molecules (>100 allotypes) as monomers, tetramers, and easYmers, with easYmers being highly active biotinylated MHC molecules that can be loaded with any antigen of interest. Additionally, they provide services for the measurement of peptide-MHC interactions, such as affinity and stability. Founded in 2018, immunAware is a spin-out from the lab of prof. Søren Buus at the University of Copenhagen, which boasts over 35 years of experience in MHC biochemistry. The startup operates in the Biotechnology and Life Sciences industries, demonstrating a strong focus on immune monitoring T cells. While the specific headquarters and past investments are not provided, the expertise of the founding team and the innovative nature of their products makes immunAware a compelling opportunity for potential investors in the biotechnology space.

Business keywords: Immune Monitoring, T cell biology, MHC Class I, MHC Class II, Recombinant MHC molecules, Peptide-MHC interactions, Immunogenecity assessment, MHC binding motifs, Immunotherapy, HLA Typing, Tetramer Development, Cellular Immunology, Life Sciences, Research Services

No funding data available for immunAware ApS yet.

immunAware ApS Alternatives & Competitors

immunAware ApS vs
Pepmic Co., Ltd
Pepmic Co., Ltd China

Committed to Lifescience

10 employees
Biotechnology, Life Sciences

FAQ About immunAware ApS

Immune Monitoring T cells
immunAware ApS was founded in 2018.
immunAware ApS is headquartered in Denmark.
immunAware ApS operates in Biotechnology and Life Sciences. Its work centres on Immune Monitoring, T cell biology, MHC Class I and MHC Class II.
immunAware ApS has approximately 8 employees.
Top alternatives and competitors to immunAware ApS include Pepmic Co., Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
immunAware ApS and Pepmic Co., Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for immunAware ApS, https://bouncewatch.com/company/immunaware-aps, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout